Symbols / RKDA Stock $1.06 +0.00% Arcadia Biosciences, Inc.
RKDA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. Arcadia Biosciences, Inc. was incorporated in 2002 and is headquartered in Dallas, Texas.
Ratings
Current target
$1.06
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-08-21 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-23 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-04-05 | reit | HC Wainwright & Co. | Buy → Buy | $10 |
| 2023-08-28 | main | HC Wainwright & Co. | Buy → Buy | $10 |
| 2023-07-24 | reit | HC Wainwright & Co. | Buy → Buy | $15 |
| 2023-06-05 | main | HC Wainwright & Co. | Buy → Buy | $15 |
| 2023-04-14 | main | HC Wainwright & Co. | — → Buy | $18 |
- Arcadia Biosciences stock (US03020Q1058): Shares drop 5% to $4.31 on July 22 - AD HOC NEWS ue, 12 May 2026 16
- RKDA stock rises pre-market after company receives merger termination notice from Roosevelt Resources - MSN Mon, 27 Apr 2026 10
- Arcadia Biosciences, Inc. Announces Termination of Securities Exchange Agreement with Roosevelt Resources, LP - Quiver Quantitative Fri, 26 Dec 2025 08
- Arcadia Biosciences (NASDAQ: RKDA) details 2025 board, compensation and option deal - Stock Titan hu, 30 Apr 2026 07
- Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds - Yahoo Finance Mon, 12 Jan 2026 08
- TradingKey - TradingKey Mon, 11 May 2026 23
- Will Arcadia Biosciences (RKDA) Stock Hit New Highs | Price at $1.37, Up 1.32% - Seasonal Patterns - Xã Vĩnh Công Mon, 06 Apr 2026 07
- RKDA Arcadia Biosciences posts massive Q3 2025 earnings beat, shares remain flat as revenue dips 3.7 percent year over year. - Rating Upgrade - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 21
- Should You Consider Buying Arcadia Biosciences Stock? - StocksToTrade Wed, 15 Oct 2025 07
- Arcadia Biosciences (RKDA) Faces Terminated Agreement, Eyes Stra - GuruFocus Fri, 26 Dec 2025 08
- Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights - Yahoo Finance hu, 14 Aug 2025 07
- Arcadia Biosciences (Nasdaq: RKDA) trims 2025 loss as Zola sales grow - Stock Titan hu, 26 Mar 2026 07
- symbol__ Stock Quote Price and Forecast - CNN hu, 15 Feb 2024 23
- Why Origin Agritech Stock Soared 92% After Hours? - Australian Oilseeds Hldgs (NASDAQ:COOT), Arcadia Bios - Benzinga Wed, 15 Oct 2025 07
- What is the volatility of Arcadia Biosciences (RKDA) Stock | Price at $1.31, Down 1.13% - Growth Picks - Xã Thanh Hà ue, 07 Apr 2026 07
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
4.86
-3.71%
|
5.04
+13.27%
|
4.45
-39.96%
|
7.42
|
| Operating Revenue |
|
4.86
-3.71%
|
5.04
+13.27%
|
4.45
-39.96%
|
7.42
|
| Cost Of Revenue |
|
3.10
+4.56%
|
2.96
+36.29%
|
2.17
-64.37%
|
6.10
|
| Reconciled Cost Of Revenue |
|
3.10
+4.56%
|
2.96
+36.29%
|
2.17
-64.37%
|
6.10
|
| Gross Profit |
|
1.76
-15.47%
|
2.08
-8.68%
|
2.28
+73.12%
|
1.32
|
| Operating Expense |
|
11.76
+21.26%
|
9.69
+16.82%
|
8.30
-49.85%
|
16.55
|
| Research And Development |
|
0.01
-83.02%
|
0.05
-17.19%
|
0.06
-95.76%
|
1.51
|
| Selling General And Administration |
|
7.00
-27.38%
|
9.64
+17.09%
|
8.23
-45.24%
|
15.04
|
| Total Expenses |
|
14.85
+17.35%
|
12.66
+20.87%
|
10.47
-53.76%
|
22.65
|
| Operating Income |
|
-9.99
-31.31%
|
-7.61
-26.49%
|
-6.02
+60.48%
|
-15.23
|
| Total Operating Income As Reported |
|
-2.50
+31.47%
|
-3.65
+40.22%
|
-6.10
+56.44%
|
-14.01
|
| EBITDA |
|
-9.96
-32.86%
|
-7.50
-30.85%
|
-5.73
+61.14%
|
-14.75
|
| Normalized EBITDA |
|
-15.10
-51.14%
|
-9.99
-63.35%
|
-6.12
+68.12%
|
-19.18
|
| Reconciled Depreciation |
|
0.03
-71.68%
|
0.11
-60.63%
|
0.29
-40.08%
|
0.48
|
| EBIT |
|
-9.99
-31.31%
|
-7.61
-26.49%
|
-6.02
+60.48%
|
-15.23
|
| Total Unusual Items |
|
5.13
+106.18%
|
2.49
+548.44%
|
0.38
-91.33%
|
4.43
|
| Total Unusual Items Excluding Goodwill |
|
5.13
+106.18%
|
2.49
+548.44%
|
0.38
-91.33%
|
4.43
|
| Special Income Charges |
|
2.75
-30.63%
|
3.96
+4819.05%
|
-0.08
-106.88%
|
1.22
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
0.04
-68.14%
|
0.11
-62.46%
|
0.30
|
| Restructuring And Mergern Acquisition |
|
-2.00
|
0.00
|
0.00
+100.00%
|
-0.07
|
| Net Income |
|
-2.34
+66.77%
|
-7.04
+49.66%
|
-13.98
+9.07%
|
-15.38
|
| Pretax Income |
|
-2.33
+45.90%
|
-4.31
+19.02%
|
-5.32
+50.80%
|
-10.81
|
| Net Non Operating Interest Income Expense |
|
0.22
-71.74%
|
0.78
+12.52%
|
0.69
+140.48%
|
0.29
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
0.22
-71.74%
|
0.78
+12.52%
|
0.69
+140.48%
|
0.29
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Interest Income Non Operating |
|
0.22
-71.74%
|
0.78
+12.52%
|
0.69
+140.48%
|
0.29
|
| Interest Income |
|
0.22
-71.74%
|
0.78
+12.52%
|
0.69
+140.48%
|
0.29
|
| Other Income Expense |
|
7.44
+195.24%
|
2.52
+125950.00%
|
0.00
-99.95%
|
4.12
|
| Other Non Operating Income Expenses |
|
2.31
+7348.39%
|
0.03
+108.12%
|
-0.38
-25.25%
|
-0.30
|
| Gain On Sale Of Security |
|
2.38
+261.74%
|
-1.47
-414.96%
|
0.47
-85.42%
|
3.21
|
| Gain On Sale Of Business |
|
—
|
—
|
0.00
-100.00%
|
1.14
|
| Tax Provision |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
-42.86%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+20900.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.08
+106.18%
|
0.52
+548.44%
|
0.08
+1720.32%
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.34
+66.77%
|
-7.04
+49.68%
|
-13.99
+10.42%
|
-15.61
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.34
+45.82%
|
-4.32
+18.91%
|
-5.32
+49.74%
|
-10.59
|
| Net Income From Continuing And Discontinued Operation |
|
-2.34
+66.77%
|
-7.04
+49.66%
|
-13.98
+9.07%
|
-15.38
|
| Net Income Continuous Operations |
|
-2.34
+45.82%
|
-4.32
+18.99%
|
-5.33
+50.79%
|
-10.83
|
| Net Income Discontinuous Operations |
|
0.00
+100.00%
|
-2.72
+68.57%
|
-8.66
-80.96%
|
-4.78
|
| Minority Interests |
|
—
|
0.00
-100.00%
|
0.01
-97.88%
|
0.24
|
| Normalized Income |
|
-6.39
-1.76%
|
-6.28
-11.67%
|
-5.63
+62.53%
|
-15.02
|
| Net Income Common Stockholders |
|
-2.34
+66.77%
|
-7.04
+49.66%
|
-13.98
+9.07%
|
-15.38
|
| Diluted EPS |
|
-1.71
+66.92%
|
-5.17
+54.21%
|
-11.29
+55.98%
|
-25.65
|
| Basic EPS |
|
-1.71
+66.92%
|
-5.17
+54.21%
|
-11.29
+55.98%
|
-25.65
|
| Basic Average Shares |
|
1.37
+0.35%
|
1.36
+10.22%
|
1.24
+106.37%
|
0.60
|
| Diluted Average Shares |
|
1.37
+0.35%
|
1.36
+10.22%
|
1.24
+106.37%
|
0.60
|
| Diluted NI Availto Com Stockholders |
|
-2.34
+66.77%
|
-7.04
+49.66%
|
-13.98
+9.07%
|
-15.38
|
| Gain On Sale Of PPE |
|
0.75
-81.25%
|
4.00
+13693.10%
|
0.03
-90.76%
|
0.31
|
| Provision For Doubtful Accounts |
|
4.75
|
0.00
|
—
|
—
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
-0.29
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
19.70
|
| Current Assets |
|
14.97
|
| Cash Cash Equivalents And Short Term Investments |
|
11.64
|
| Cash And Cash Equivalents |
|
6.52
|
| Other Short Term Investments |
|
5.12
|
| Receivables |
|
0.51
|
| Accounts Receivable |
|
0.51
|
| Gross Accounts Receivable |
|
0.51
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
| Inventory |
|
0.84
|
| Raw Materials |
|
—
|
| Finished Goods |
|
—
|
| Prepaid Assets |
|
—
|
| Assets Held For Sale Current |
|
1.18
|
| Other Current Assets |
|
0.81
|
| Total Non Current Assets |
|
4.73
|
| Net PPE |
|
0.86
|
| Gross PPE |
|
2.80
|
| Accumulated Depreciation |
|
-1.94
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.42
|
| Other Properties |
|
0.79
|
| Leases |
|
1.59
|
| Goodwill And Other Intangible Assets |
|
0.04
|
| Goodwill |
|
—
|
| Other Intangible Assets |
|
0.04
|
| Other Non Current Assets |
|
3.83
|
| Total Liabilities Net Minority Interest |
|
7.00
|
| Current Liabilities |
|
3.59
|
| Payables And Accrued Expenses |
|
1.97
|
| Payables |
|
0.54
|
| Accounts Payable |
|
0.48
|
| Other Payable |
|
0.04
|
| Current Accrued Expenses |
|
1.43
|
| Current Debt And Capital Lease Obligation |
|
0.85
|
| Current Capital Lease Obligation |
|
0.85
|
| Current Deferred Liabilities |
|
—
|
| Current Deferred Revenue |
|
—
|
| Other Current Liabilities |
|
0.77
|
| Total Non Current Liabilities Net Minority Interest |
|
3.41
|
| Long Term Debt And Capital Lease Obligation |
|
0.15
|
| Long Term Capital Lease Obligation |
|
0.15
|
| Other Non Current Liabilities |
|
2.00
|
| Stockholders Equity |
|
12.84
|
| Common Stock Equity |
|
12.84
|
| Capital Stock |
|
0.07
|
| Common Stock |
|
0.07
|
| Share Issued |
|
1.29
|
| Ordinary Shares Number |
|
1.29
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
284.51
|
| Retained Earnings |
|
-271.84
|
| Gains Losses Not Affecting Retained Earnings |
|
0.10
|
| Minority Interest |
|
-0.14
|
| Other Equity Adjustments |
|
0.10
|
| Total Equity Gross Minority Interest |
|
12.70
|
| Total Capitalization |
|
12.84
|
| Working Capital |
|
11.38
|
| Invested Capital |
|
12.84
|
| Total Debt |
|
1.01
|
| Capital Lease Obligations |
|
1.01
|
| Net Tangible Assets |
|
12.80
|
| Tangible Book Value |
|
12.80
|
| Derivative Product Liabilities |
|
1.26
|
| Dueto Related Parties Current |
|
0.06
|
| Non Current Note Receivables |
|
0.00
|
| Notes Receivable |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.74
+50.77%
|
-9.63
+37.05%
|
-15.29
-9.42%
|
-13.98
|
| Cash Flow From Continuing Operating Activities |
|
-4.74
+50.77%
|
-9.63
+37.05%
|
-15.29
-9.42%
|
-13.98
|
| Net Income From Continuing Operations |
|
-2.34
+66.77%
|
-7.04
+49.68%
|
-13.99
+10.42%
|
-15.61
|
| Depreciation Amortization Depletion |
|
0.03
-71.68%
|
0.11
-60.63%
|
0.29
-40.08%
|
0.48
|
| Depreciation |
|
0.03
-71.68%
|
0.11
-60.63%
|
0.29
-34.62%
|
0.44
|
| Amortization Cash Flow |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Depreciation And Amortization |
|
0.03
-71.68%
|
0.11
-60.63%
|
0.29
-40.08%
|
0.48
|
| Amortization Of Intangibles |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Other Non Cash Items |
|
0.37
+204.79%
|
-0.35
-105.51%
|
6.44
+3185.20%
|
0.20
|
| Stock Based Compensation |
|
0.23
-54.30%
|
0.51
-28.59%
|
0.72
-35.17%
|
1.11
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.33
-43.15%
|
0.58
-83.35%
|
3.46
|
| Deferred Tax |
|
—
|
—
|
—
|
—
|
| Deferred Income Tax |
|
—
|
—
|
—
|
—
|
| Operating Gains Losses |
|
-3.13
-20.96%
|
-2.59
+60.65%
|
-6.58
-41.26%
|
-4.66
|
| Gain Loss On Investment Securities |
|
-2.38
-261.74%
|
1.47
+122.52%
|
-6.54
-103.93%
|
-3.21
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
-0.75
+81.55%
|
-4.07
-10062.50%
|
-0.04
+87.26%
|
-0.31
|
| Change In Working Capital |
|
0.10
+116.11%
|
-0.60
+78.28%
|
-2.74
-361.33%
|
1.05
|
| Change In Receivables |
|
0.17
+121.65%
|
-0.76
-514.13%
|
0.18
-68.92%
|
0.59
|
| Changes In Account Receivables |
|
—
|
—
|
0.18
-68.92%
|
0.59
|
| Change In Inventory |
|
-0.31
-156.00%
|
0.55
+122.74%
|
-2.42
-316.37%
|
1.12
|
| Change In Prepaid Assets |
|
0.78
+725.00%
|
-0.12
-12500.00%
|
0.00
-98.90%
|
0.09
|
| Change In Payables And Accrued Expense |
|
-0.43
-29.22%
|
-0.33
+35.16%
|
-0.51
+33.76%
|
-0.77
|
| Change In Payable |
|
-0.43
-29.22%
|
-0.33
+35.16%
|
-0.51
+33.76%
|
-0.77
|
| Change In Account Payable |
|
-0.40
-31.68%
|
-0.30
+41.95%
|
-0.52
+31.04%
|
-0.76
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
—
|
| Change In Other Current Assets |
|
-0.05
-169.44%
|
0.07
+3500.00%
|
0.00
-87.50%
|
0.02
|
| Change In Other Current Liabilities |
|
-0.06
|
0.00
|
0.00
-100.00%
|
0.01
|
| Investing Cash Flow |
|
0.75
-89.78%
|
7.34
+269.01%
|
-4.34
-406.56%
|
1.42
|
| Cash Flow From Continuing Investing Activities |
|
0.75
-89.78%
|
7.34
+269.01%
|
-4.34
-406.56%
|
1.42
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
0.32
+189.09%
|
0.11
-87.03%
|
0.85
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.02
-220.00%
|
-0.01
+93.06%
|
-0.07
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.33
+190.43%
|
0.12
-87.50%
|
0.92
|
| Capital Expenditure |
|
—
|
-0.02
-220.00%
|
-0.01
+93.06%
|
-0.07
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
5.02
+200.02%
|
-5.02
|
0.00
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-7.53
|
0.00
|
| Sale Of Investment |
|
0.00
-100.00%
|
5.02
+100.80%
|
2.50
|
0.00
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-2.00
-451.49%
|
0.57
+0.00%
|
0.57
|
| Purchase Of Business |
|
0.00
+100.00%
|
-2.00
|
0.00
|
0.00
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
0.00
+100.00%
|
-1.14
|
| Net Intangibles Purchase And Sale |
|
0.75
-81.25%
|
4.00
|
0.00
|
—
|
| Financing Cash Flow |
|
0.01
-33.33%
|
0.01
-99.84%
|
5.51
+21.97%
|
4.52
|
| Cash Flow From Continuing Financing Activities |
|
0.01
-33.33%
|
0.01
-99.84%
|
5.51
+21.97%
|
4.52
|
| Net Issuance Payments Of Debt |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
—
|
0.00
-100.00%
|
6.00
+19.94%
|
5.00
|
| Proceeds From Stock Option Exercised |
|
0.01
-33.33%
|
0.01
-25.00%
|
0.01
+71.43%
|
0.01
|
| Net Other Financing Charges |
|
—
|
—
|
-0.50
-1.84%
|
-0.49
|
| Changes In Cash |
|
-3.98
-75.00%
|
-2.28
+83.89%
|
-14.13
-75.67%
|
-8.04
|
| Effect Of Exchange Rate Changes |
|
—
|
—
|
—
|
0.00
|
| Beginning Cash Position |
|
4.24
-34.92%
|
6.52
-68.43%
|
20.64
-28.03%
|
28.68
|
| End Cash Position |
|
0.26
-93.89%
|
4.24
-34.92%
|
6.52
-68.43%
|
20.64
|
| Free Cash Flow |
|
-4.74
+50.86%
|
-9.64
+36.97%
|
-15.30
-8.90%
|
-14.05
|
| Interest Paid Supplemental Data |
|
—
|
—
|
0.00
-100.00%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
—
|
0.00
|
| Amortization Of Securities |
|
—
|
—
|
—
|
—
|
| Common Stock Issuance |
|
—
|
0.00
-100.00%
|
6.00
+19.94%
|
5.00
|
| Issuance Of Capital Stock |
|
—
|
0.00
-100.00%
|
6.00
+19.94%
|
5.00
|
| Sale Of Business |
|
—
|
0.00
-100.00%
|
0.57
+0.00%
|
0.57
|
| Sale Of Intangibles |
|
0.75
-81.25%
|
4.00
|
0.00
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-03 View
- 10-K2026-03-26 View
- 8-K2026-03-26 View
- 8-K2026-02-06 View
- 8-K2026-01-14 View
- 8-K2025-12-29 View
- 8-K2025-12-23 View
- 10-Q2025-11-07 View
- 8-K2025-11-07 View
- 8-K2025-10-24 View
- 8-K2025-08-29 View
- 10-Q2025-08-14 View
- 8-K2025-08-14 View
- 8-K2025-05-16 View
- 42025-05-12 View
- 42025-05-12 View
- 10-Q2025-05-08 View
- 8-K2025-05-08 View
- 8-K2025-05-02 View
- 8-K2025-04-03 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|